SONIDEGIB for Basal cell naevus syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where SONIDEGIB was used for Basal cell naevus syndrome.
Most Reported Side Effects for SONIDEGIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Muscle spasms | 182 | 12.9% | 8 | 18 |
| Alopecia | 107 | 7.6% | 7 | 9 |
| Off label use | 100 | 7.1% | 2 | 2 |
| Fatigue | 94 | 6.7% | 4 | 7 |
| Death | 87 | 6.2% | 75 | 4 |
| Product use issue | 70 | 5.0% | 1 | 0 |
| Nausea | 69 | 4.9% | 3 | 10 |
| Product dose omission issue | 66 | 4.7% | 0 | 0 |
| Therapy cessation | 64 | 4.5% | 1 | 2 |
| Ageusia | 59 | 4.2% | 1 | 3 |
| Asthenia | 59 | 4.2% | 2 | 15 |
| Decreased appetite | 58 | 4.1% | 2 | 23 |
| Weight decreased | 58 | 4.1% | 3 | 9 |
| Blood creatine phosphokinase increased | 56 | 4.0% | 8 | 14 |
| Diarrhoea | 54 | 3.8% | 9 | 3 |
Other Indications for SONIDEGIB
Basal cell carcinoma (900)
Product used for unknown indication (270)
Myelodysplastic syndrome (25)
Skin cancer (21)
Acute myeloid leukaemia (20)
Triple negative breast cancer (17)
Medulloblastoma (14)
Neoplasm malignant (14)
Skin neoplasm excision (11)
Pancreatic carcinoma (10)